Our Network

• Celerion
  Celerion is a global leader in early-phase clinical research, specializing in translating science into medicine. They conduct clinical trials for new drugs, focusing on pharmacokinetics, pharmacodynamics, and safety evaluation. Celerion has had a strong presence in Belfast for over 20 years. Celerion will take up residence in iREACH Health, allowing them to expand their activities in Belfast and build upon their existing ties with Queen’s University, Belfast and Belfast City Hospital. Celerion offers expertise in patient recruitment, protocol design, and regulatory guidance. Their work accelerates drug development, helping bring innovative therapies to market efficiently. 

• Northern Ireland Clinical Research Network
• Northern Ireland Clinical Trials Unit
• Northern Ireland Cancer Trials Network
• HSC Approval Service
• HSC Research Office
• HSC Innovations
• Belfast Trust
• HSC Research & Development

Momentum One Zero is a global innovation centre led by Queen's University Belfast, focusing on data-driven research and innovation in advanced digital technologies. It aims to address business and societal challenges across sectors such as digital health, agri-food, and cybersecurity. Momentum One Zero and iREACH Health have a shared focus on the use of data-driven innovation to improve healthcare. There is potential for future collaborations between the two centres on AI and machine learning to optimize clinical trials.

Momentum One Zero | Queen's University Belfast

AMIC is an initiative aimed at revitalising Northern Ireland's industrial sector by providing advanced manufacturing facilities and expertise. A key development is the construction of a 10,500m² state-of-the-art Factory of the Future, designed to support innovation and collaboration in manufacturing processes and technologies. The opportunity exists for iREACH Health and AMIC to collaborate on sustainable nanotech applications for medical devices/diagnostics and treatments.

Advanced Manufacturing Innovation Centre | Queen's University Belfast

The Future Medicines Institute is a consortium led by Queen's University Belfast, established to drive innovation and productivity in precision medicine within Northern Ireland. There is scope to partner on novel therapeutics identified by FMI, which could be brought to market through clinical trials carried out at iREACH Health.

Future Medicines Institute | Business | Queen's University Belfast

The Centre for Digital Healthcare Technology is set to be an exemplary hub for digital technology and associated living labs in areas such as cardiology, diabetes, respiratory, and stroke. It will serve as a collaborative platform for academia, industry, and clinicians to lead research focused on global health challenges, including healthcare costs and healthy ageing. The CDHT and iREACH Health have some overlapping interests in the improvement of healthcare by focusing on data-driven innovations. There is much potential for the two centres to collaborate towards providing new healthcare solutions.

Centre for Digital Health Technology